We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current FBIO market cap is 50.24M. The company's latest EPS is USD -2.4876 and P/E is -0.73.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 34.75M | 19.95M | 13.03M | 14.9M | 14.63M |
| Operating Income | -13.76M | -16.51M | -36.57M | -25.14M | -24.84M |
| Net Income | -7.05M | -11.29M | -15.42M | -10.95M | -19.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 36.63M | 45.6M | 68.79M | 75.74M | 84.51M |
| Operating Income | -110.82M | -94.27M | -188.54M | -203.56M | -139.24M |
| Net Income | -39.96M | -46.53M | -64.7M | -86.58M | -68.67M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 150.55M | 167.53M | 164.65M | 145.69M | 127.09M |
| Total Liabilities | 163.79M | 165.94M | 168.58M | 160.28M | 139.82M |
| Total Equity | -13.24M | 1.59M | -3.94M | -14.6M | -12.74M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 226.42M | 328.83M | 396.5M | 294.3M | 167.53M |
| Total Liabilities | 153.89M | 131.84M | 170.63M | 244.28M | 165.94M |
| Total Equity | 72.53M | 197M | 225.88M | 50.03M | 1.59M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -93.29M | -128.23M | -25.39M | -47.23M | -67.28M |
| Investing | -2.04M | -2.1M | N/A | N/A | N/A |
| Financing | -10.88M | 32.74M | 27.86M | 42.12M | 44.84M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -94.96M | -83.68M | -116.54M | -179.4M | -128.23M |
| Investing | 20.1M | -7.16M | 40.51M | -22.93M | -2.1M |
| Financing | 146.71M | 172.41M | 148.99M | 75.32M | 32.74M |
| Market Cap | 50.24M |
| Price to Earnings Ratio | -0.73 |
| Price to Sales Ratio | 0.59 |
| Price to Cash Ratio | 0.62 |
| Price to Book Ratio | 31.66 |
| Dividend Yield | - |
| Shares Outstanding | 27.6M |
| Average Volume (1 week) | 218.64k |
| Average Volume (1 Month) | 419.95k |
| 52 Week Change | -0.55% |
| 52 Week High | 2.89 |
| 52 Week Low | 1.355 |
| Spread (Intraday) | 0.1 (5.52%) |
| Company Name | Fortress Biotech Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.fortressbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
